Poland· PL-100375493

Fibrovein

A sodium tetradecyl sulfate product containing natrii tetradecylis sulfas, registered in Poland by STD Pharmaceutical (Ireland) Limited. The same ATC class is registered in 6 of our 19 countries.

ATC C05BB04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedFibroveinATCC05BB04REGISTER NO.PL-100375493PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Sodium tetradecyl sulfate is registered in 6 of 19 countries.

Countries holding a registration under ATC C05BB04 (sodium tetradecyl sulfate), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose

Sodium tetradecyl sulfate · ATC C05BB04

6 / 19 countries

  • Canada
  • Czechiaprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Natrii tetradecylis sulfas
Manufacturer
STD Pharmaceutical (Ireland) Limited
Country
Poland (PL)
ATC code
C05BB04
ATC class
Sodium tetradecyl sulfate
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909991332969
  • gtin
    05909991332976
  • gtin
    05909991332983
  • gtin
    05909991332990

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sodium tetradecyl sulfate in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sodium tetradecyl sulfate products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Germany · Fibrovein
  • Spain · Veinfibro
  • France · Fibrovein, Trombovar
  • Ireland · Fibrovein
  • Italy · Fibrovein
  • Romania · Fibrovein

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b9798f48-4c05-497e-9c9b-f8ea4adce7ae
GET /v1/drugs/b9798f48-4c05-497e-9c9b-f8ea4adce7ae?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań",
  "source": "urpl",
  "strength": "3% (30 mg/ml)",
  "packaging": "05909991332969 ¦ Rp ¦ 122619\n2 fiol. 5 ml\n05909991332976 ¦ Rp ¦ 122620\n5 fiol. 5 ml\n05909991332983 ¦ Rp ¦ 122621\n5 amp. 2 ml\n05909991332990 ¦ Rp ¦ 122622\n10 fiol. 5 ml",
  "substance": "Natrii tetradecylis sulfas 3% (30 mg/ml)",
  "common_name": "Natrii tetradecylis sulfas",
  "pl_product_id": "100375493",
  "pozwolenie_nr": "24036",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}

See everything about sodium tetradecyl sulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.